Trial Profile
Phase I trial of tranexamic acid [LB1148] in cardiovascular surgery patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jul 2015
Price :
$35
*
At a glance
- Drugs Tranexamic acid (Primary)
- Indications Cardiogenic shock; Multiple organ failure; Septic shock
- Focus Adverse reactions
- 07 Jul 2015 New trial record